Relentless Health Value

Erik serves as a Managing Director in the Accenture Health Client Service Group where he manages a large team of healthcare professionals within the Clinical and Health Management Services team. He serves as the Managing Director for Healthcare Provider Technology Consulting in North America, as well as Accenture's Blockchain lead across the healthcare service line and as a co-lead of Accenture's Value Based Care practice in North America. In his role, he partners with senior client executives to develop and drive healthcare transformation strategies, guide healthcare investment decisions, develop innovation roadmaps for new use of health IT, and build transformation programs in support of population health, care management, value based care, and interoperability initiatives. He also has extensive responsibilities for a diverse portfolio of sales and business development activities at major Accenture healthcare clients and leads a wide range of provider and payer sales opportunities across North America. Erik has worked for over 20 years in healthcare, including senior positions in federal, state, and commercial healthcare programs and initiatives, and served in key leadership roles within the healthcare community. He holds leadership advisory positions within the American Health Information Management Association (AHIMA), the Healthcare Information and Management Systems Society (HIMSS), and the Healthcare Financial Management Association (HFMA), and regularly speaks at industry conferences on trends influencing the healthcare industry. He received a certification as a Certified Professional in Healthcare Information & Management Systems (CHPIMS) in 2009 and became a HIMSS Fellow in 2012. You can learn more at accenture.com.

Stacey is co-president of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other healthcare organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient.

00:00 The largest healthcare payers in the country. 01:45 Asking Patients to be good Healthcare Consumers. 03:30 Labeling Healthcare Consumers. 04:10 “A significant portion of the population does not consider themselves a healthcare consumer.” 06:00 Identifying vs. not identifying as a Healthcare Consumer. 07:40 What most marketing behavior is motivated by. 09:10 The need for employers to demand change. 10:15 What to do to build and encourage Healthcare Consumerism. 10:25 Refer to Dave Chase’s book, or his interview on our podcast, EP107. 10:50 Our podcast interview with Richard Steinhart, EP149. 11:10 The one type of person who might actually consider themselves a full-time Healthcare Consumer. 15:45 “What do we need to do to help everyone in this country realize that we are Healthcare Consumers?” 16:00 “How can we improve the scales to actually be the agents of change that everyone is depending on?”

Stacey is co-president of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other healthcare organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. 00:00 The largest healthcare payers in the country. 01:45 Asking Patients to be good Healthcare Consumers. 03:30 Labeling Healthcare Consumers. 04:10 "A significant portion of the population does not consider themselves a healthcare consumer." 06:00 Identifying vs. not identifying as a Healthcare Consumer. 07:40 What most marketing behavior is motivated by. 09:10 The need for employers to demand change. 10:15 What to do to build and encourage Healthcare Consumerism. 10:25 Refer to Dave Chase's book, or his interview on our podcast, EP107. 10:50 Our podcast interview with Richard Steinhart, EP149. 11:10 The one type of person who might actually consider themselves a full-time Healthcare Consumer. 15:45 "What do we need to do to help everyone in this country realize that we are Healthcare Consumers?" 16:00 "How can we improve the scales to actually be the agents of change that everyone is depending on?"

Prescription errors cause patient harm, that’s indisputable, and the literature is filthy with examples of all kinds of variations on the theme. Today I speak with MedAware CEO & Co-Founder, Dr. Gidi Stein. MedAware is laser focused on eliminating prescription errors using AI/Machine Learning to flag mistakes in real-time. His system is 80% effective, exponentially more effective than our current algorithm based drug interaction and other rules engines.

Gidi Stein, MD, PhD. A practicing physician, researcher and serial entrepreneur. Co-founder and CEO of MedAware, dedicated to eliminate prescription errors and promote patient safety, using big-data analytics and machine-learning algorithms. Gidi also teaches medicine in Tel Aviv Medical School and treats complex patients in Rabin Medical Center, Israel. You can learn more by visiting medaware.com.

Dhruv Khullar, M.D., M.P.P. is a physician at NewYork-Presbyterian Hospital and a researcher at the Weill Cornell Department of Healthcare Policy and Research. He is also a contributor at the New York Times, where he explores the intersection of medicine, health policy, and economics. He recently worked in the ABC News Medical Unit, helping to curate and communicate evolving health stories, and was previously at the White House Office of Management and Budget (O.M.B.), focusing on Affordable Care Act implementation.

Dr. Khullar completed his training in internal medicine at the Massachusetts General Hospital and Harvard Medical School, and earned his medical degree (M.D.) at the Yale School of Medicine. He also received a Masters in Public Policy (M.P.P.) from the Harvard Kennedy School, where he was a fellow at the Center for Public Leadership. 

His work has appeared in the New England Journal of Medicine, Journal of the American Medical Association (JAMA), New York Times, Washington Post, Wall Street Journal, USA Today, The Atlantic, Slate, and other lay and academic publications. He was recently recognized by LinkedIn as one of the Top 10 Healthcare Professionals Under 35.

Thank you to Jim Klus-Salisbury for his help with this episode. @Outcomes_guru ; outcomesguru.blogspot.com

You can learn more by following Dhruv’s writing in the Well section of the New York Times and The Upshot.

Dhruv Khullar, M.D., M.P.P. is a physician at NewYork-Presbyterian Hospital and a researcher at the Weill Cornell Department of Healthcare Policy and Research. He is also a contributor at the New York Times, where he explores the intersection of medicine, health policy, and economics. He recently worked in the ABC News Medical Unit, helping to curate and communicate evolving health stories, and was previously at the White House Office of Management and Budget (O.M.B.), focusing on Affordable Care Act implementation. Dr. Khullar completed his training in internal medicine at the Massachusetts General Hospital and Harvard Medical School, and earned his medical degree (M.D.) at the Yale School of Medicine. He also received a Masters in Public Policy (M.P.P.) from the Harvard Kennedy School, where he was a fellow at the Center for Public Leadership. His work has appeared in the New England Journal of Medicine, Journal of the American Medical Association (JAMA), New York Times, Washington Post, Wall Street Journal, USA Today, The Atlantic, Slate, and other lay and academic publications. He was recently recognized by LinkedIn as one of the Top 10 Healthcare Professionals Under 35. Thank you to Jim Klus-Salisbury for his help with this episode. @Outcomes_guru ; outcomesguru.blogspot.com You can learn more by following Dhruv's writing in the Well section of the New York Times and The Upshot.

In inbetweenisode 14, I laid out my vision for Amazon in the pharmacy space. You’re welcome, Amazon. In this episode, I had the privilege of speaking with Pramod John, who sums up the four structural roadblocks Amazon will face if they decide to gin up a pharmacy division. One of his points I find particularly key - Getting cheap convenient drugs from Amazon is not the point, it’s their huge opportunity to reinvent how Pharmacy works.

Pramod John is team leader of VIVIO Health, a company that is reinventing the therapeutic use and supply chain for the specialty drug space. VIVIO Health's solution is challenging the current framework of efficacy and extending it to true effectiveness in the real world. It also offers significant drug acquisition savings and simplicity for the patient by integrating the supply chain into a unified and data driven process. Prior to VIVIO Health, Pramod was founder of Oration PBC (acquired by Pokitdok) which was focused on giving back consumers control over their drug purchasing by capturing the prescription in the physician's office and providing real time pricing options and automatic routing capabilities. Pramod was also VP of Strategy and Innovation at McKesson, the world's largest healthcare company. At McKesson, Pramod helped develop solutions that leveraged advanced technologies and business process improvements to optimize healthcare delivery systems, infrastructure and supply chains. Earlier, Pramod founded and served as CEO of PacketMotion, Inc., a venture-funded startup in the enterprise network information and policy management industry. The company was later acquired by VMWare. In addition, Pramod founded netExaminer.com, a managed-vulnerability assessment company acquired by SonicWALL (owned by Dell). Pramod earned his Ph.D. in Electrical Engineering from the University of Illinois at Urbana-Champaign. He serves on the Boards of Mission Aviation Fellowship, a global relief organization and 3 Crosses Church in Castro Valley, CA. He also serves on the advisory board of Folia Water and as a mentor at StartX. You can learn more at www.viviohealth.com.

Ethan Basch, MD talks today about a randomized clinical trial where 766 patients used a web-based system to self-report symptoms, triggering alerts to clinicians. The results were impressive. There are learnings and inspiration in this episode for anyone pursuing better patient outcomes, with special relevance for organizations rolling with a value-based care model.